Enhancement of sensitivity using hybrid stimulus for the diagnosis of prostate cancer based on polydiacetylene (PDA) supramolecules

Il Kyoung Kwon, Jun Pyo Kim, Sang Jun Sim

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

In this study, hybrid stimulus was initially introduced to improve the sensitivity of PDA vesicle chip for detection of prostate-specific antigen-α1-antichymotrypsin (PSA-ACT) complex. The strategy of hybrid stimulus on PDA vesicle chip offers the amplification method of fluorescent signal which combines a primary response by the immune reaction of antigen-antibody and a secondary response by the mechanical pressure of pAb-conjugated magnetic beads. As the primary response result on PDA vesicle chip, the PSA-ACT complex in PBS buffer was detected at 10. ng/mL. However, this detection sensitivity was insufficient for diagnosis of prostate cancer because the normal human PSA concentration is less than 4.0. ng/mL. To solve this problem, polyclonal PSA antibody-conjugated magnetic beads were used as an amplifying agent after primary immunoresponse. As a result, the PSA-ACT complex concentrations (as low as 0.1. ng/mL) could be detected in the PBS buffer sample. Therefore, this result can be applied to various fields, such as the detection of cells, proteins, and DNA for sensitive and specific biosensing based on PDA supramolecules.

Original languageEnglish
Pages (from-to)1548-1553
Number of pages6
JournalBiosensors and Bioelectronics
Volume26
Issue number4
DOIs
Publication statusPublished - 2010 Dec 15
Externally publishedYes

Fingerprint

Antigens
Prostatic Neoplasms
Prostate-Specific Antigen
Antibodies
Buffers
Antigen-antibody reactions
Histocompatibility Antigens Class II
Amplification
DNA
Proteins
Pressure
polydiacetylene

Keywords

  • Biosensor
  • Magnetic bead
  • Polydiacetylene
  • Prostate cancer

ASJC Scopus subject areas

  • Biophysics
  • Biomedical Engineering
  • Biotechnology
  • Electrochemistry

Cite this

Enhancement of sensitivity using hybrid stimulus for the diagnosis of prostate cancer based on polydiacetylene (PDA) supramolecules. / Kwon, Il Kyoung; Kim, Jun Pyo; Sim, Sang Jun.

In: Biosensors and Bioelectronics, Vol. 26, No. 4, 15.12.2010, p. 1548-1553.

Research output: Contribution to journalArticle

@article{060fcf4086924529a788f32533b8df09,
title = "Enhancement of sensitivity using hybrid stimulus for the diagnosis of prostate cancer based on polydiacetylene (PDA) supramolecules",
abstract = "In this study, hybrid stimulus was initially introduced to improve the sensitivity of PDA vesicle chip for detection of prostate-specific antigen-α1-antichymotrypsin (PSA-ACT) complex. The strategy of hybrid stimulus on PDA vesicle chip offers the amplification method of fluorescent signal which combines a primary response by the immune reaction of antigen-antibody and a secondary response by the mechanical pressure of pAb-conjugated magnetic beads. As the primary response result on PDA vesicle chip, the PSA-ACT complex in PBS buffer was detected at 10. ng/mL. However, this detection sensitivity was insufficient for diagnosis of prostate cancer because the normal human PSA concentration is less than 4.0. ng/mL. To solve this problem, polyclonal PSA antibody-conjugated magnetic beads were used as an amplifying agent after primary immunoresponse. As a result, the PSA-ACT complex concentrations (as low as 0.1. ng/mL) could be detected in the PBS buffer sample. Therefore, this result can be applied to various fields, such as the detection of cells, proteins, and DNA for sensitive and specific biosensing based on PDA supramolecules.",
keywords = "Biosensor, Magnetic bead, Polydiacetylene, Prostate cancer",
author = "Kwon, {Il Kyoung} and Kim, {Jun Pyo} and Sim, {Sang Jun}",
year = "2010",
month = "12",
day = "15",
doi = "10.1016/j.bios.2010.07.109",
language = "English",
volume = "26",
pages = "1548--1553",
journal = "Biosensors",
issn = "0956-5663",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Enhancement of sensitivity using hybrid stimulus for the diagnosis of prostate cancer based on polydiacetylene (PDA) supramolecules

AU - Kwon, Il Kyoung

AU - Kim, Jun Pyo

AU - Sim, Sang Jun

PY - 2010/12/15

Y1 - 2010/12/15

N2 - In this study, hybrid stimulus was initially introduced to improve the sensitivity of PDA vesicle chip for detection of prostate-specific antigen-α1-antichymotrypsin (PSA-ACT) complex. The strategy of hybrid stimulus on PDA vesicle chip offers the amplification method of fluorescent signal which combines a primary response by the immune reaction of antigen-antibody and a secondary response by the mechanical pressure of pAb-conjugated magnetic beads. As the primary response result on PDA vesicle chip, the PSA-ACT complex in PBS buffer was detected at 10. ng/mL. However, this detection sensitivity was insufficient for diagnosis of prostate cancer because the normal human PSA concentration is less than 4.0. ng/mL. To solve this problem, polyclonal PSA antibody-conjugated magnetic beads were used as an amplifying agent after primary immunoresponse. As a result, the PSA-ACT complex concentrations (as low as 0.1. ng/mL) could be detected in the PBS buffer sample. Therefore, this result can be applied to various fields, such as the detection of cells, proteins, and DNA for sensitive and specific biosensing based on PDA supramolecules.

AB - In this study, hybrid stimulus was initially introduced to improve the sensitivity of PDA vesicle chip for detection of prostate-specific antigen-α1-antichymotrypsin (PSA-ACT) complex. The strategy of hybrid stimulus on PDA vesicle chip offers the amplification method of fluorescent signal which combines a primary response by the immune reaction of antigen-antibody and a secondary response by the mechanical pressure of pAb-conjugated magnetic beads. As the primary response result on PDA vesicle chip, the PSA-ACT complex in PBS buffer was detected at 10. ng/mL. However, this detection sensitivity was insufficient for diagnosis of prostate cancer because the normal human PSA concentration is less than 4.0. ng/mL. To solve this problem, polyclonal PSA antibody-conjugated magnetic beads were used as an amplifying agent after primary immunoresponse. As a result, the PSA-ACT complex concentrations (as low as 0.1. ng/mL) could be detected in the PBS buffer sample. Therefore, this result can be applied to various fields, such as the detection of cells, proteins, and DNA for sensitive and specific biosensing based on PDA supramolecules.

KW - Biosensor

KW - Magnetic bead

KW - Polydiacetylene

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=78649734335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649734335&partnerID=8YFLogxK

U2 - 10.1016/j.bios.2010.07.109

DO - 10.1016/j.bios.2010.07.109

M3 - Article

VL - 26

SP - 1548

EP - 1553

JO - Biosensors

JF - Biosensors

SN - 0956-5663

IS - 4

ER -